Rex Capital Advisors’s Novartis NVS Stock Holding History

Rex Capital Advisors’s Portfolio NVS Stock Details NVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-3,650	Closed	-$323K	–	43
2015 Q1	$323K	Hold	3,650	–	–	0.3%	41
2014 Q4	$303K	Hold	3,650	–	–	0.29%	47
2014 Q3	$308K	Hold	3,650	–	–	0.3%	44
2014 Q2	$296K	Hold	3,650	–	–	0.26%	46
2014 Q1	$278K	Hold	3,650	–	–	0.28%	43
2013 Q4	$263K	Hold	3,650	–	–	0.29%	46
2013 Q3	$251K	Hold	3,650	–	–	0.28%	44
2013 Q2	$231K	Buy	+3,650	New	+$237K	0.19%	47

Other funds holding NVS

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

BBHC

Brown Brothers Harriman & Co New York $22.8B AUM 25.09% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

MAA

Managed Account Advisors Jersey City, New Jersey $121B AUM 7.32% 1-Year Est. Return

Rex Capital Advisors's NVS Position: Q2 2015 in Review

Rex Capital Advisors sold out of Novartis (NVS) in Q2 2015, closing a stake of 3,650 shares — an estimated $323K sold.

Rex Capital Advisors first reported a position in NVS in Q2 2013 and held it in 8 quarters. The position peaked at $323K in Q1 2015. 945 funds tracked by Wall St. Rank hold NVS as of Q2 2015.

Rex Capital Advisors reported no remaining Novartis position as of Q2 2015 after selling out during the quarter.
Rex Capital Advisors sold 3,650 Novartis shares in Q2 2015, an estimated $323K.
Rex Capital Advisors first reported a position in Novartis in Q2 2013 and held it in 8 quarters.
Rex Capital Advisors's Novartis position peaked at $323K in Q1 2015.
945 funds tracked by Wall St. Rank held Novartis as of Q2 2015.

Based on Rex Capital Advisors's 13F filing for Q2 2015, filed 14 Aug 2015.